Efficacy of Mesenchymal Stem Cells in Knee Osteoarthritis: A Clinical Outcomes Review
Background / Problem
Knee osteoarthritis is the most common cause of knee pain. It arises from degeneration of the articular cartilage together with reduced quality and quantity of joint fluid, leading to pain, stiffness, reduced range of motion, and a lower quality of life. Conventional treatments such as analgesics and joint replacement surgery are often limited by side effects and lengthy recovery times.
This piece reviews the use of mesenchymal stem cells (MSCs) as an option for treating knee osteoarthritis, summarizing the mechanism of action and the outcomes reported in clinical research.
Approach & Mechanism
MSC therapy for knee osteoarthritis relies on injecting cells directly into the joint to stimulate regeneration of degenerated cartilage and to reduce inflammation through paracrine signaling. Stem cells can be derived from various sources, but tissue-derived cells — particularly adipose or umbilical cord tissue — are preferred.
- 1Assess disease severity and patient suitability
- 2Isolate and prepare mesenchymal stem cells in a standard laboratory
- 3Inject the cells directly into the knee under sterile technique
- 4Follow up on pain, joint function, and quality of life after treatment
Outcomes
Multiple clinical studies report that patients receiving intra-articular stem cell injection tend to experience reduced pain and improved joint function, alongside a favorable safety profile. Outcomes may vary with disease severity and the source of the cells.
- Stem cells help stimulate cartilage repair and reduce inflammation within the joint
- Multiple studies report favorable outcomes for pain reduction and mobility
- May be considered as an option before joint replacement in suitable patients
Key Findings / Insights
- MSCs are well suited to degenerative conditions such as knee osteoarthritis because they support repair and reduce inflammation directly
- The commonly used cell sources are adipose tissue and umbilical cord tissue
- Appropriate patient selection and standardized procedure are key factors for outcomes
References
- Thai Rheumatism Association. Guideline for the Treatment of Osteoarthritis of the Knee. 2010. https://www.thairheumatology.org/wp-content/uploads/2016/08/Guideline-for-Management-of-OA-knee.pdf
- Zelman D. Osteoarthritis of the Knee (Degenerative Arthritis of the Knee). WebMD, Jun 2021. https://www.webmd.com/osteoarthritis/ostearthritis-of-the-knee-degenerative-arthritis-of-the-knee
- Zelman D. What's New in Knee Osteoarthritis Treatments? WebMD, Jun 2021. https://www.webmd.com/osteoarthritis/knee-arthritis-treatment-advances
- Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. Journal of Medical Case Reports. 2011;5(1):1-8.
Related Resources
Frequently Asked Questions (FAQs)
Is the knee stem cell injection painful?
The procedure is an intra-articular injection performed with local anesthesia, and most patients feel only mild discomfort. A physician should assess individual suitability beforehand.
When will results appear?
The time to see results varies between individuals. Most patients gradually feel reduced pain and improved mobility over time, depending on the condition of the joint and individual care.